Pharmaceutical Biocatalysis: Important Enzymes, Novel Targets, and Therapies (Jenny Stanford Series on Biocatalysis)
Zoomicon-zoom-in
Pharmaceutical Biocatalysis: Important Enzymes, Novel Targets, and Therapies (Jenny Stanford Series on Biocatalysis)

Pharmaceutical Biocatalysis: Important Enzymes, Novel Targets, and Therapies (Jenny Stanford Series on Biocatalysis)

By
Peter Grunwald (Contributor)  

Hardback

In Stock

Quantity

Also available on eBook for £173.69. Click here to purchase from Rakuten Kobo

This volume of Pharmaceutical Biocatalysis starts with a discussion on the importance of biocatalytic synthesis approaches for a sustainable and environmentally friendly production of pharmaceuticals and active pharmaceutical ingredients. Among the enzymes discussed in detail with respect to their pharmaceutical relevance are cyclic nucleotide phosphodiesterases playing an important role in modulating signal transduction in various cell types; human DOPA decarboxylase, related to Parkinson's disease and aromatic amino acid decarboxylase deficiency; and phospholipase D enzymes as drug targets. Isocitrate dehydrogenase 1 and 2 mutations are novel therapeutic targets in acute myeloid leukemia. An additional chapter is devoted to the use of enzymes for prodrug activation in cancer therapy. The other topics include small-molecule inhibitors targeting receptor tyrosine kinases in cancer, -Lactams and related compounds as antibacterials, non-vitamin K oral anticoagulants for the treatment of thromboembolic diseases, and the molecular mechanisms for statin pleiotropy and its clinical relevance in cardiovascular diseases. The last chapter is a review of lysosomal storage disorders with an overview of approved drugs for treating these disorders by enzyme replacement therapy.
Peter Grunwald studied chemistry at the Universities of Saarbrucken and Hamburg, Germany. He graduated in the field of high-frequency spectroscopy and then became a staff member of the Institute of Physical Chemistry. After receiving his PhD in physical chemistry, he founded a biotechnology research group. He was appointed professor in 2001. His research interests focus on immobilized biocatalysts, kinetics of enzymes in organic solvents, and interactions between biocatalysts and heavy metal ions. Prof. Grunwald is also interested in chemical education, including curriculum development. He has authored a textbook on biochemistry and is an editorial board member of Catalysts.
  • Contributor: Peter Grunwald
  • Imprint: Jenny Stanford Publishing
  • ISBN13: 9789814877138
  • Number of Pages: 460
  • Packaged Dimensions: 152x229mm
  • Packaged Weight: 1040
  • Format: Hardback
  • Publisher: Jenny Stanford Publishing
  • Release Date: 2020-11-02
  • Series: Jenny Stanford Series on Biocatalysis
  • Binding: Hardback
  • Biography: Peter Grunwald studied chemistry at the Universities of Saarbrucken and Hamburg, Germany. He graduated in the field of high-frequency spectroscopy and then became a staff member of the Institute of Physical Chemistry. After receiving his PhD in physical chemistry, he founded a biotechnology research group. He was appointed professor in 2001. His research interests focus on immobilized biocatalysts, kinetics of enzymes in organic solvents, and interactions between biocatalysts and heavy metal ions. Prof. Grunwald is also interested in chemical education, including curriculum development. He has authored a textbook on biochemistry and is an editorial board member of Catalysts.

Delivery Options

Home Delivery

Store Delivery

Free Returns

We hope you are delighted with everything you buy from us. However, if you are not, we will refund or replace your order up to 30 days after purchase. Terms and exclusions apply; find out more from our Returns and Refunds Policy.